The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
The role of substance P in stress and anxiety responses
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ljungdahl, Å., Hökfelt, T., & Nilsson, G. (1978) · Neuroscience · doi:10.1016/0306-4522(78)90116-1 · Cited by 1,432
Neurotransmitter functions of mammalian tachykinins.
Otsuka, M., & Yoshioka, K. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.2.229 · Cited by 1,080
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors
Kramer, M. S., Cutler, N., Feighner, J., Shrivastava, R., Carman, J., Sramek, J. J., Reines, S. A., Liu, G., Snavely, D., Wyatt-Knowles, E., et al. (1998) · Science · doi:10.1126/science.281.5383.1640 · Cited by 1,071
Landgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059
Substance P: Localization in the Central Nervous System and in Some Primary Sensory Neurons
Hökfelt, T., Kellerth, J. O., Nilsson, G., & Pernow, B. (1975) · Science · doi:10.1126/science.242075 · Cited by 1,025
A Potent Nonpeptide Antagonist of the Substance P (NK 1 ) Receptor
Snider, R. M., Constantine, J. W., Lowe, J. A., Longo, K. P., Lebel, W. S., Woody, H. A., Drozda, S. E., Desai, M. C., Vinick, F. J., Spencer, R. W., et al. (1991) · Science · doi:10.1126/science.1703323 · Cited by 859
Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation
HOLSBOER, F., & BARDEN, N. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-187 · Cited by 852
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
Vertes, R. P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130409 · Cited by 842 · cited 1×
“…of the SP=NK1 receptor system with monoaminergic sys- tems: In the dorsal raphe nucleus, the major source of 5-HT projections to forebrain areas (Vertes, 1991), both SP immunoreactive cells=fibers (Warden and Young, 1988; Nakaya et al., 1994) as well as NK1 receptors have been described…”
BackgroundNucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor
Nawa, H., Hirose, T., Takashima, H., Inayama, S., & Nakanishi, S. (1983) · Nature · doi:10.1038/306032a0 · Cited by 755
Severini, C., Improta, G., Falconieri-Erspamer, G., Salvadori, S., & Erspamer, V. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.285 · Cited by 637
Receptors and antagonists for substance P and related peptides.
Regoli, D., Boudon, A., & Fauchére, J. L. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06810-3 · Cited by 631
Maes, M., Meltzer, H. Y., Bosmans, E., Bergmans, R., Vandoolaeghe, E., Ranjan, R., & Desnyder, R. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00028-l · Cited by 622 · cited 1×
“Notably, this pro- inflammatory cytokine has been shown to be elevated during the acute depressive state (Maes et al., 1995; Frommberger et al., 1997).”
BackgroundHökfelt, T., Broberger, C., Xu, Z.-Q. D., Sergeyev, V., Ubink, R., & Diez, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00010-1 · Cited by 604
Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing
Nawa, H., Kotani, H., & Nakanishi, S. (1984) · Nature · doi:10.1038/312729a0 · Cited by 571
Herkenham, M. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90268-5 · Cited by 520
Mammalian Tachykinin Receptors
Nakanishi, S. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.001011 · Cited by 497
The mammalian tachykinin receptors
Maggi, C. A. (1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(94)00292-u · Cited by 486
Nakaya, Y., Kaneko, T., Shigemoto, R., Nakanishi, S., & Mizuno, N. (1994) · Journal of Comparative Neurology · doi:10.1002/cne.903470208 · Cited by 408
Frommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362 · cited 1×
“Notably, this pro- inflammatory cytokine has been shown to be elevated during the acute depressive state (Maes et al., 1995; Frommberger et al., 1997).”
BackgroundMantyh, P., Gates, T., Mantyh, C., & Maggio, J. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-01-00258.1989 · Cited by 329
Warden, M. K., & Young, W. S. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902720107 · Cited by 315
Distribution of neuropeptides in the limbic system of the rat: The amygdaloid complex
Roberts, G. W., Woodhams, P. L., Polak, J. M., & Crow, T. J. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90156-7 · Cited by 312
Shults, C. W., Quirion, R., Chronwall, B., Chase, T. N., & O'Donohue, T. L. (1984) · Peptides · doi:10.1016/0196-9781(84)90177-3 · Cited by 312
Santarelli, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041596398 · Cited by 303
Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis
Zhang, Y., Lu, L., Furlonger, C., Wu, G. E., & Paige, C. J. (2000) · Nature Immunology · doi:10.1038/80826 · Cited by 302
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
Quartara, L., & Maggi, C. A. (1998) · Neuropeptides · doi:10.1016/s0143-4179(98)90015-4 · Cited by 292
Mantyh, P. W., Allen, C. J., Ghilardi, J. R., Rogers, S. D., Mantyh, C. R., Liu, H., Basbaum, A. I., Vigna, S. R., & Maggio, J. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2622 · Cited by 290
Pickel, V. M., Joh, T. H., Reis, D. J., Leeman, S. E., & Miller, R. J. (1979) · Brain Research · doi:10.1016/0006-8993(79)91068-0 · Cited by 289
Keller, M., Montgomery, S., Ball, W., Morrison, M., Snavely, D., Liu, G., Hargreaves, R., Hietala, J., Lines, C., Beebe, K., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.013 · Cited by 286
Neumann, I. D., Krömer, S. A., Toschi, N., & Ebner, K. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00197-x · Cited by 285
Self-citationHigh vs Low Anxiety-Related Behavior Rats: An Animal Model of Extremes in Trait Anxiety
Landgraf, R., & Wigger, A. (2002) · Behavior Genetics · doi:10.1023/a:1020258104318 · Cited by 274
Nakajima, Y., Tsuchida, K., Negishi, M., Ito, S., & Nakanishi, S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45898-x · Cited by 261
Tachykinins: receptor to effector
Khawaja, A. M., & Rogers, D. F. (1996) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/1357-2725(96)00017-9 · Cited by 257
Kramer, M. S., Winokur, A., Kelsey, J., Preskorn, S. H., Rothschild, A. J., Snavely, D., Ghosh, K., Ball, W. A., Reines, S. A., Munjack, D., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300260 · Cited by 256
Structure and gene organization of bovine neuromedin K precursor.
Kotani, H., Hoshimaru, M., Nawa, H., & Nakanishi, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.7074 · Cited by 233
Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus
Florin-Lechner, S. M., Druhan, J. P., Aston-Jones, G., & Valentino, R. J. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00967-5 · Cited by 226
Ebner, K., Rupniak, N. M., Saria, A., & Singewald, N. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400794101 · Cited by 225
Self-citationBeresford, I. J. M., Birch, P. J., Hagan, R. M., & Ireland, S. J. (1991) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1991.tb12423.x · Cited by 219
Mantyh, P. W., Hunt, S. P., & Maggio, J. E. (1984) · Brain Research · doi:10.1016/0006-8993(84)90470-0 · Cited by 216
Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist
Gether, U., Johansen, T. E., Snider, R. M., Lowe, J. A., Nakanishi, S., & Schwartz, T. W. (1993) · Nature · doi:10.1038/362345a0 · Cited by 210
Furmark, T., Appel, L., Michelgård, Å., Wahlstedt, K., Åhs, F., Zancan, S., Jacobsson, E., Flyckt, K., Grohp, M., Bergström, M., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.029 · Cited by 206
The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation
Quartara, L., & Maggi, C. A. (1997) · Neuropeptides · doi:10.1016/s0143-4179(97)90001-9 · Cited by 205
The tachykinin NK1 receptor in the brain: pharmacology and putative functions
Saria, A. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00259-9 · Cited by 204
The dual nature of the tachykinin NK1 receptor
Maggi, C. A., & Schwartz, T. W. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01107-3 · Cited by 203
Distribution of the substance P receptor (NK-1 receptor) in the central nervous system
Maeno, H., Kiyama, H., & Tohyama, M. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90172-l · Cited by 202
Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain
Saffroy, M., Beaujouan, J. C., Torrens, Y., Besseyre, J., Bergström, L., & Glowinski, J. (1988) · Peptides · doi:10.1016/0196-9781(88)90255-0 · Cited by 201
Lieb, K., Fiebich, B. L., Berger, M., Bauer, J., & Schulze-Osthoff, K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4952 · Cited by 191
Excitation of neurons in the nucleus locus coeruleus by substance P and related peptides
Guyenet, P. G., & Aghajanian, G. K. (1977) · Brain Research · doi:10.1016/0006-8993(77)90144-5 · Cited by 191
Köhler, C., Chan‐Palay, V., & Steinbusch, H. (1982) · Journal of Comparative Neurology · doi:10.1002/cne.902090109 · Cited by 188
Neuroanatomical localisation of Substance P in the CNS and sensory neurons
Ribeiro-da-Silva, A., & Hökfelt, T. (2000) · Neuropeptides · doi:10.1054/npep.2000.0834 · Cited by 185
Localization of the neuromedin K receptor (NK3) in the central nervous system of the rat
Ding, Y., Shigemoto, R., Takada, M., Ohishi, H., Nakanishi, S., & Mizuno, N. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960108)364:2<290::aid-cne8>3.0.co;2-0 · Cited by 178
Rupniak, N. M. J., Carlson, E. C., Harrison, T., Oates, B., Seward, E., Owen, S., de Felipe, C., Hunt, S., & Wheeldon, A. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00052-6 · Cited by 168
Keck, M. E., Welt, T., Müller, M. B., Uhr, M., Ohl, F., Wigger, A., Toschi, N., Holsboer, F., & Landgraf, R. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300040 · Cited by 168
Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain
Caberlotto, L., Hurd, Y. L., Murdock, P. R., Wahlin, J.-P., Melotto, S., Corsi, M., & Carletti, R. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02600.x · Cited by 167
Teixeira, R. M., Santos, A. R. S., Ribeiro, S. J., Calixto, J. B., Rae, G. A., & De Lima, T. C. M. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00390-1 · Cited by 166
The psychobiology of anxiolytic drugs
Sandford, J. J., Argyropoulos, S. V., & Nutt, D. J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00082-6 · Cited by 165
Page, N. M. (2004) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-004-4035-x · Cited by 164
The psychobiology of anxiolytic drugs
Argyropoulos, S. V., Sandford, J. J., & Nutt, D. J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00083-8 · Cited by 163
van der Hart, M. G. C., Czéh, B., de Biurrun, G., Michaelis, T., Watanabe, T., Natt, O., Frahm, J., & Fuchs, E. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001130 · Cited by 158
Gall, C., & Moore, R. Y. (1984) · Journal of Comparative Neurology · doi:10.1002/cne.902250207 · Cited by 158
Rupniak, N. M. J., Carlson, E. J., Webb, J. K., Harrison, T., Porsolt, R. D., Roux, S., Felipe, C. D., Hunt, S. P., Oates, B. D., & Wheeldon, A. (2001) · Behavioural Pharmacology · doi:10.1097/00008877-200111000-00011 · Cited by 151
Allen, B. J., Rogers, S. D., Ghilardi, J. R., Menning, P. M., Kuskowski, M. A., Basbaum, A. I., Simone, D. A., & Mantyh, P. W. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05921.1997 · Cited by 147
Strategies for producing faster acting antidepressants
Adell, A., Castro, E., Celada, P., Bortolozzi, A., Pazos, Á., & Artigas, F. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03398-2 · Cited by 145
Kachidian, P., Poulat, P., Marlier, L. N. J. L., & Privat, A. (1991) · Journal of Neuroscience Research · doi:10.1002/jnr.490300309 · Cited by 144
Spooren, W. P. J. M., Schoeffter, P., Gasparini, F., Kuhn, R., & Gentsch, C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01562-x · Cited by 140
Froger, N., Gardier, A. M., Moratalla, R., Alberti, I., Léna, I., Boni, C., Felipe, C. D., Rupniak, N. M. J., Hunt, S. P., Jacquot, C., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08188.2001 · Cited by 140
Lindefors, N., Brodin, E., Tossman, U., Segovia, J., & Ungerstedt, U. (1989) · Experimental Brain Research · doi:10.1007/bf00247354 · Cited by 138
Czeh, B., Simon, M., van der Hart, M. G., Schmelting, B., Hesselink, M. B., & Fuchs, E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300581 · Cited by 136
Fiebich, B. L., Schleicher, S., Butcher, R. D., Craig, A., & Lieb, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.10.5606 · Cited by 133
Duric, V., & McCarson, K. E. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.002 · Cited by 133
Saffroy, M., Torrens, Y., Glowinski, J., & Beaujouan, J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00748-0 · Cited by 129
Nicholas, A. P., Pieribone, V. A., Arvidsson, U., & Hökfelt, T. G. M. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90401-m · Cited by 129
Substance P Receptor Antagonists in Psychiatry: Rationale for Development and Therapeutic Potential
Herpfer, I., & Lieb, K. (2005) · CNS Drugs · doi:10.2165/00023210-200519040-00001 · Cited by 123
Born to be anxious: neuroendocrine and genetic correlates of trait anxiety in HAB rats
Landgraf, R., & Wigger, A. (2003) · Stress · doi:10.1080/1025389031000104193 · Cited by 122
Molecular basis for the species selectivity of the substance P antagonist CP-96,345.
Sachais, B. S., Snider, R. M., Lowe, J. A., III, & Krause, J. E. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53777-7 · Cited by 119
Varty, G. B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00313-5 · Cited by 119
Microdialysis measurement of in vivo neuropeptide release
Kendrick, K. M. (1990) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(90)90040-m · Cited by 118
Gadd, C. A., Murtra, P., Felipe, C. D., & Hunt, S. P. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-23-08271.2003 · Cited by 114
Shirayama, Y., Mitsushio, H., Takashima, M., Ichikawa, H., & Takahashi, K. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00812-8 · Cited by 113
Neurokinin1 Receptor Antagonists as Potential Antidepressants
Stout, S. C., Owens, M. J., & Nemeroff, C. B. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.877 · Cited by 110
Aguiar, M. S., & Brandão, M. L. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(96)00156-4 · Cited by 108
Anxiolytic Action of a Neurokinin1 Receptor Antagonist in the Social Interaction Test
File, S. E. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)90002-2 · Cited by 107
Central tachykinins: mediators of defence reaction and stress reactions
Čulman, J., & Unger, T. (1995) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-122 · Cited by 98
Neuropeptide expression in rats exposed to chronic mild stresses
Sergeyev, V., Fetissov, S. O., Mathé, A. A., Jimenez, P. A., Bartfai, T., Mortas, P., Gaudet, L., Moreau, J., & H�kfelt, T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2015-3 · Cited by 97
Antinociceptive activity of NK1 receptor antagonists: non‐specific effects of racemic RP67580
Rupniak, N. M. J., Boyce, S., Williams, A. R., Cook, G., Longmore, J., Seabrook, G. R., Caeser, M., Iversen, S. D., & Hill, R. G. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb14008.x · Cited by 95
Bittencourt, J. C., Benoit, R., & Sawchenko, P. E. (1991) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(91)90032-8 · Cited by 95
ROSÉN, A., Brodin, K., Eneroth, P. H. E., & Brodin, E. (1992) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1992.tb09428.x · Cited by 91
Hahn, M. K., & Bannon, M. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00319-x · Cited by 90
Substance P release from the rat substantia nigra
Jessell, T. M. (1978) · Brain Research · doi:10.1016/0006-8993(78)91080-6 · Cited by 90
Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization.
Unger, T., Carolus, S. M., Demmert, G., et al. (1988) · Circulation Research · doi:10.1161/01.res.63.4.812 · Cited by 90
Multiple intracellular signaling pathways of the neuropeptide substance P receptor
Mitsuhashi, M., Ohashi, Y., Shichijo, S., Christian, C., Sudduth-Klinger, J., Harrowe, G., & Payan, D. G. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490320315 · Cited by 87
Brodin, E., Rosén, A., Schött, E., & Brodin, K. (1994) · Neuropeptides · doi:10.1016/0143-4179(94)90079-5 · Cited by 85
Takeda, Y., Blount, P., Sachais, B. S., et al. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb09430.x · Cited by 85
Do Substance P and the NK1 Receptor have a Role in Depression and Anxiety?
McLean, S. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053764779 · Cited by 85
Hamon, M., GOZLAN, H., Bourgoin, S., Benoliel, J. J., Mauborgne, A., Taquet, H., Cesselin, F., & Micó, J. A. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90144-4 · Cited by 84
Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus
Commons, K. G., & Valentino, R. J. (2002) · The Journal of Comparative Neurology · doi:10.1002/cne.10228 · Cited by 84
Papp, M., Vassout, A., & Gentsch, C. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00230-8 · Cited by 82
Čulman, J., Klee, S., Ohlendorf, C., & Unger, T. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36365-7 · Cited by 82
Larsen, P. J. (1992) · The Journal of Comparative Neurology · doi:10.1002/cne.903160304 · Cited by 82
Substance P (Neurokinin 1) Receptor Antagonists Enhance Dorsal Raphe Neuronal Activity
Conley, R. K., Cumberbatch, M. J., Mason, G. S., Williamson, D. J., Harrison, T., Locker, K. L., Swain, C. J., Maubach, K. A., O’Donnell, R., Rigby, M., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-17-07730.2002 · Cited by 81
Anxiolytics: past, present, and future agents.
Nemeroff, C. B. (2003) · PubMed · Cited by 80
Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats
Krase, W., Koch, M., & Schnitzler, H. (1994) · Behavioural Brain Research · doi:10.1016/0166-4328(94)90053-1 · Cited by 80
Siegel, R. A., Düker, E.-M., Pahnke, U., & Wuttke, W. (2008) · Neuroendocrinology · doi:10.1159/000124799 · Cited by 79
Cheeta, S., Tucci, S. A., Sandhu, J., Williams, A. R., Rupniak, N. M. J., & File, S. E. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02846-3 · Cited by 78
Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission
Haddjeri, N., & Blier, P. U. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01162-3 · Cited by 77
Gobbi, G., & Blier, P. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.032 · Cited by 77
Neurokinins Activate Local Glutamatergic Inputs to Serotonergic Neurons of the Dorsal Raphe Nucleus
Liu, R. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00305-6 · Cited by 77
Varty, G. B., Cohen-Williams, M. E., & Hunter, J. C. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200302000-00009 · Cited by 77
Substance P excitation of rat locus coeruleus neurones
Cheeseman, H. J., Pinnock, R. D., & Henderson, G. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90445-4 · Cited by 75
Jessop, D. S., Renshaw, D. W., Larsen, P. J., Chowdrey, H. S., & Harbuz, M. S. (2000) · Stress · doi:10.3109/10253890009001125 · Cited by 75
Stiller, C., Linderoth, B., O'Connor, W. T., Franck, J., Falkenberg, T., Ungerstedt, U., & Brodin, E. (1995) · Brain Research · doi:10.1016/0006-8993(95)00911-9 · Cited by 74
Smith, D. W., Hewson, L., Fuller, P. J., Williams, A. R., Wheeldon, A., & Rupniak, N. M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01976-9 · Cited by 73
Larsen, P. J., Jessop, D. S., Patel, H., Lightman, S. L., & Chowdrey, H. S. (1993) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1993.tb00368.x · Cited by 73
Boyce, S., Smith, D., Carlson, E. J., Hewson, L., Rigby, M., O’Donnell, R., Harrison, T., & Rupniak, N. M. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00051-x · Cited by 72
Maubach, K. A., Martin, K., Chicchi, G. G., Harrison, T., Wheeldon, A., Swain, C. J., Cumberbatch, M. J., Rupniak, N. M. J., & Seabrook, G. R. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00467-5 · Cited by 72
Sekizawa, S., Joad, J. P., & Bonham, A. C. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00547.x · Cited by 71
Chowdrey, H. S., Jessop, D. S., & Lightman, S. L. (2008) · Neuroendocrinology · doi:10.1159/000125544 · Cited by 70
Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat
Dableh, L. J., Yashpal, K., Rochford, J. M., & Henry, J. L. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.11.024 · Cited by 70
Ryckmans, T., Balançon, L., Berton, O., Génicot, C., Lamberty, Y., Lallemand, B., Pasau, P., Pirlot, N., Quéré, L., & Talaga, P. E. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00727-2 · Cited by 70
NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats
File, S. E. (2000) · Psychopharmacology · doi:10.1007/s002130000513 · Cited by 70
Activation by stress of the habenulo-interpeduncular substance P neurons in the rat
Lisoprawski, A., Blanc, G., & Glowinski, J. (1981) · Neuroscience Letters · doi:10.1016/0304-3940(81)90099-9 · Cited by 67
Léger, L., Charnay, Y., Hof, P. R., Bouras, C., & Cespuglio, R. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1133 · Cited by 66
Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain
Baulmann, J., Spitznagel, H., Herdegen, T., Unger, T., & Čulman, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00478-9 · Cited by 66
Halliday, G. M., Li, Y.-W., JOH, T. H., Cotton, R. G. H., Howe, P. R. C., Geffen, L. B., & Blessing, W. W. (1988) · Synapse · doi:10.1002/syn.890020403 · Cited by 66
Santarelli, L., Gobbi, G., Blier, P., & Hen, R. (2002) · PubMed · Cited by 65
Millan, M. J., Lejeune, F., Nanteuil, G. D., & Gobert, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00211.x · Cited by 65
Hasenöhrl, R. U., Jentjens, O., Silva, M. A. D. S., Tomaz, C. A. B., & Huston, J. P. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00441-5 · Cited by 65
Future Antidepressants: What is in the Pipeline and What is Missing?
Bosker, F. J., Westerink, B. H. C., Cremers, T. I. F. H., Gerrits, M., van der Hart, M. G. C., Kuipers, S. D., van der Pompe, G., Horst, G. J. T., den Boer, J. A., & Korf, J. (2004) · CNS Drugs · doi:10.2165/00023210-200418110-00002 · Cited by 64
Siegel, R. A., Düker, E., Fuchs, E., Pahnke, U., & Wuttke, W. (1984) · Neurochemistry International · doi:10.1016/0197-0186(84)90011-1 · Cited by 63
Zocchi, A., Varnier, G., Arban, R., Griffante, C., Zanetti, L., Bettelini, L., Marchi, M., Gerrard, P. A., & Corsi, M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00305-7 · Cited by 63
Effect of immobilization stress on neuropeptides and their receptors in rat central nervous system
Takayama, H., Ota, Z., & Ogawa, N. (1986) · Regulatory Peptides · doi:10.1016/0167-0115(86)90065-0 · Cited by 63
Peptide autoreceptors: does an autoreceptor for substance P exist?
Malcangio, M., & Bowery, N. G. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01388-7 · Cited by 63
Valentino, R. J., Bey, V., Pernar, L. I. M., & Commons, K. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07155.2003 · Cited by 62
Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage
Fornai, M., Natale, G., Colucci, R., Tuccori, M., Carazzina, G., Antonioli, L., Baldi, S., Lubrano, V., Abramo, A. C., Blandizzi, C., et al. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-005-1075-1 · Cited by 61
Effect of lithium on tachykinins, calcitonin gene‐related peptide, and neuropeptide Y in rat brain
Mathé, A. A., Jousisto‐Hanson, J., Stenfors, C., & Theodorsson, E. (1990) · Journal of Neuroscience Research · doi:10.1002/jnr.490260213 · Cited by 61
Ballard, T. M., Sänger, S., & Higgins, G. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00724-5 · Cited by 60
Husum, H., Vasquez, P. A., & Mathé, A. A. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00198-6 · Cited by 59
Potts, J. T., Fuchs, I. E., Li, J., Leshnower, B. G., & Mitchell, J. H. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.829ad.x · Cited by 59
Aguiar, M. S., & Brandão, M. L. (1994) · Behavioural Pharmacology · doi:10.1097/00008877-199406000-00017 · Cited by 58
Reduction of guinea pig pup isolation calls by anxiolytic and antidepressant drugs
Molewijk, H. E., Hartog, K., van der Poel, A. M., Mos, J., & Olivier, B. (1996) · Psychopharmacology · doi:10.1007/s002130050106 · Cited by 56
Rosén, A., Zhang, Y., Lund, I., Lundeberg, T., & Yu, L. (2004) · Brain Research · doi:10.1016/j.brainres.2003.11.060 · Cited by 55
Vassout, A., Veenstra, S. J., Hauser, K. L., Ofner, S., Brugger, F., Schilling, W., & Gentsch, C. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00194-4 · Cited by 54
Herpfer, I., Hunt, S. P., & Stanford, S. C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.12.016 · Cited by 52
Nikolaus, S., Huston, J. P., & Hasenöhrl, R. U. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00105-3 · Cited by 51
Involvement of the D-2 dopamine receptor in the neuroleptic-induced decrease in nigral substance P
Oblin, A., Živković, B., & Bartholini, G. (1984) · European Journal of Pharmacology · doi:10.1016/0014-2999(84)90664-2 · Cited by 51
Effects of lithium and haloperidol administration on the rat brain levels of substance P.
Hong, J., Ha, T., & Yoshikawa, K. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33520-2 · Cited by 51
Chowdreyxa, H. S., Larsen, P. J., Harbuz, M. S., Lightman, S. L., & Jessop, D. S. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02194-n · Cited by 50
Vendruscolo, L. F., Takahashi, R. N., Brüske, G. R., & Ramos, A. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1545-4 · Cited by 50
New insights into the antidepressant actions of substance P (NK1 receptor) antagonists
Rupniak, N. M. J. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-048 · Cited by 50
Effect of neurokinin-1 receptor antagonists on the function of 5-HT and noradrenaline neurons
Haddjeri, N., & Blier, P. U. (2000) · Neuroreport · doi:10.1097/00001756-200004270-00035 · Cited by 47
Elliott, P. J. (1988) · Experimental Brain Research · doi:10.1007/bf00248227 · Cited by 47
Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus
Gavioli, E. C., Canteras, N. S., & de Lima, T. C. M. (1999) · Neuroreport · doi:10.1097/00001756-199911080-00026 · Cited by 46
In vivo release of substance P in the cat substantia nigra
Michelot, R., Leviel, V., Torrens, Y., Glowinski, J., & Chéramy, A. (1979) · Neuroscience Letters · doi:10.1016/0304-3940(79)96103-2 · Cited by 46
Antidepressant Properties of Substance P Antagonists: Relationship to Monoaminergic Mechanisms?
Adell, A. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043482516 · Cited by 46
Torrens, Y., Beaujouan, J., Besson, M., et al. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90182-5 · Cited by 45
Brodin, E., Ögren, S., & Theodorsson-Norheim, E. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90151-1 · Cited by 44
Inhibition of CRH-41 release by substance P, but not substance K, from the rat hypothalamus in vitro
Faria, M. D. S., Navarra, P., Tsagarakis, S., BESSER, G. M., & Grossman, A. B. (1991) · Brain Research · doi:10.1016/0006-8993(91)90378-9 · Cited by 44
Singewald, N., Kaehler, S. T., & Philippu, A. (1999) · Neuroreport · doi:10.1097/00001756-199905140-00035 · Cited by 41
Self-citationSteinberg, R., Alonso, R., Rouquier, L., Desvignes, C., Michaud, J.-C., Cudennec, A., Jung, M., Simiand, J., Griebel, G., Emonds‐Alt, X., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.040279 · Cited by 41
The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils
Rupniak, N. M. J., Webb, J. K., Fisher, A., Smith, D. A., & Boyce, S. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00023-6 · Cited by 40
INFLUENCE OF SUBSTANCE P ON HYPOTHALAMO-PITUITARY-ADRENOCORTICAL ACTIVITY IN THE RAT
Jones, M. T., Gillham, B., Holmes, M. C., HODGES, J. R., & Buckingham, J. C. (1978) · Journal of Endocrinology · doi:10.1677/joe.0.0760183 · Cited by 38
Garcia, M., Sakamoto, K., Shigekawa, M., Nakanishi, S., & Ito, S. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90459-6 · Cited by 38
Modulation of brain stem monoamines and γ-aminobutyric acid by NK1 receptors in rats
Ma, Q., & Bleasdale, C. (2002) · Neuroreport · doi:10.1097/00001756-200210070-00024 · Cited by 38
de Araújo, J. E., Huston, J. P., & Brandão, M. L. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01460-1 · Cited by 37
Gavioli, E. C., Canteras, N. S., & de Lima, T. C. M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00054-2 · Cited by 37
RP67580, a neurokinin1 receptor antagonist, decreased restraint stress-induced defecation in rat
Ikeda, K., Miyata, K., Orita, A., Kubota, H., Yamada, T., & Tomioka, K. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11972-y · Cited by 34
Czéh, B., Pudovkina, O., van der Hart, M. G. C., Simon, M., Heilbronner, U., Michaelis, T., Watanabe, T., Frahm, J., & Fuchs, E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2184-8 · Cited by 33
Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
Sivam, S. P., Krause, J. E., Takeuchi, K., et al. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24155-6 · Cited by 32
Li, X., Geller, E. B., Liu‐Chen, L., Chen, C., & Adler, M. W. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36834-x · Cited by 31
Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils
Gentsch, C., Cutler, M. G., Vassout, A., Veenstra, S. J., & Brugger, F. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00024-4 · Cited by 31
Bert, L., Rodier, D., Bougault, I., Allouard, N., Lefur, G., Soubrié, P., & Steinberg, R. (2001) · Synapse · doi:10.1002/syn.10021 · Cited by 31
Bhatt, S., Gregg, T. R., & Siegel, A. (2003) · Brain Research · doi:10.1016/s0006-8993(02)04189-6 · Cited by 30
van der Hart, M. G. C., de Biurrun, G., Czéh, B., Rupniak, N. M. J., den Boer, J. A., & Fuchs, E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2260-0 · Cited by 30
Nikolaus, S., Huston, J. P., & Hasenöhrl, R. U. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00902-2 · Cited by 29
Ryckmans, T., Berton, O., Grimée, R., Kogej, T., Lamberty, Y., Pasau, P., Talaga, P. E., & Génicot, C. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00563-2 · Cited by 29
Duarte, F. S., Testolin, R., & de Lima, T. C. M. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.03.020 · Cited by 26
Brodin, K., ROSÉN, A., Iwarsson, K. E., ÖUGREN, S. ‐., & Brodin, E. (1989) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1989.tb08710.x · Cited by 26
Influence of passive avoidance learning by substance P in the basolateral amygdala
Lénárd, L., & Kertes, E. (2002) · Acta Biologica Hungarica · doi:10.1556/abiol.53.2002.1-2.11 · Cited by 25
Serotonin regulation of neostriatal tachykinins following neonatal 6-hydroxydopamine lesions
Walker, P. D., Riley, L. A., Hart, R. P., & Jonakait, G. M. (1991) · Brain Research · doi:10.1016/0006-8993(91)90112-9 · Cited by 24
Potts, J. T., & Fuchs, I. E. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03308-4 · Cited by 24
Nikolaus, S., Huston, J. P., & Hasenührl, R. U. (1999) · Neuroreport · doi:10.1097/00001756-199908020-00013 · Cited by 24
Lieb, K., Treffurth, Y., Hamke, M., Akundi, R. S., Kleinsorgen, M. V., & Fiebich, B. L. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01802.x · Cited by 22
Ribeiro, R. L., & de Lima, T. C. M. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00331-1 · Cited by 22
Loiseau, F., Bihan, C. L., Hamon, M., & Thiébot, M.-H. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0050-3 · Cited by 22
Hwang, B. H., Katner, J., & Iyengar, S. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:3:239 · Cited by 22
Mitsushio, H., Takashima, M., Mataga, N., & Toru, M. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24069-1 · Cited by 22
de Araújo, J. E., Huston, J. P., & Brandão, M. L. (2001) · Peptides · doi:10.1016/s0196-9781(01)00464-8 · Cited by 21
Nitric oxide involvement in the anxiogenic-like effect of substance P
Baretta, I. P., Assreuy, J., & de Lima, T. C. M. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00165-6 · Cited by 19
Brodin, K., Ögren, S. O., & Brodin, E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90538-x · Cited by 18
Lindefors, N., Brodin, K., Stiller, C., Persson, H., & Brodin, E. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90104-v · Cited by 18
Rodgers, R. J., Gentsch, C., Hoyer, D., Bryant, E., Green, A. J., Kolokotroni, K. Z., & Martin, J. L. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.02.005 · Cited by 14
Effects of deoxycorticosterone acetate and diazepam on neuropeptidergic neurons in rat striatum
Lucas, L., Pompei, P., & McEwen, B. S. (1997) · Neuroreport · doi:10.1097/00001756-199703030-00002 · Cited by 14
Teixeira, R. M., & de Lima, T. C. M. (2003) · Neuropeptides · doi:10.1016/j.npep.2003.08.002 · Cited by 13
Saleh, T. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00979-7 · Cited by 12
Behavioral and immunological effects of substance P in female and male mice
TEIXEIRA, R. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.04.032 · Cited by 12
Sartori, S. B., Burnet, P. W. J., Sharp, T., & Singewald, N. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.013 · Cited by 10
Self-citationZachrisson, O., Mathé, A. A., & Lindefors, N. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00861-8 · Cited by 9
Cited by
Wang, J., Sánchez-Roselló, M., Aceña, J. L., del Pozo, C., Sorochinsky, A. E., Fustero, S., Soloshonok, V. A., & Liu, H. (2014) · Chemical Reviews · doi:10.1021/cr4002879 · Cited by 4,847
Detecting Activated Cell Populations Using Single-Cell RNA-Seq
Wu, Y. E., Pan, L., Zuo, Y., Li, X., & Hong, W. (2017) · Neuron · doi:10.1016/j.neuron.2017.09.026 · Cited by 438
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.595584 · Cited by 440
Neurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
Bandelow, B., Baldwin, D., Abelli, M., Bolea-Alamanac, B., Bourin, M., Chamberlain, S. R., Cinosi, E., Davies, S., Domschke, K., Fineberg, N., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2016.1190867 · Cited by 347
“Substance P, a ligand of the neurokinin 1 (NK1) receptor, is released in response to stress, anxiety, and pain (Saria 1999; Carrasco & Van de Kar 2003; Ebner & Singewald 2006).”
Background
Metadata
- Authors
- Ebner, K., & Singewald, N.
- Venue
- Amino Acids
- Published
- 2006-07-06
- Volume
- 31
- Issue
- 3
- Pages
- 251-272
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- OpenAlex
- W2084988952
- Cited by
- 306
- References
- 197
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.